Suministro de los productos farmacéuticos Levatinib, Pemigarinib, Ruxolitinib y Evinacumab para el Complejo Hospitalario Universitario Insular-Materno Infantil de Gran Canaria
TED · 605241-2026Award noticeawardedNo deadline given
Value
Estimated—
Awarded€700,417 · 700,416.78 EUR
WinnerINCYTE BIOSCIENCES IBERIA, S.L.
Who already wins at this buyer
Firms with recorded awards from Consejería de Sanidad del Gobierno de Canarias in this tender’s CPV categories — the incumbents you are bidding against.
| Firm | Wins | Awarded | Last win |
|---|---|---|---|
| ABBOTT LABORATORIES, S.A. | 1 | €5,475,915 | 2026-07-10 |
| PFIZER S.L.U | 1 | €3,488,000 | 2026-05-15 |
| AGILENT TECHNOLOGIES SPAIN SL | Roche Diagnostics, S.L. | 1 | €2,950,650 | 2026-05-18 |
| FRESENIUS MEDICAL CARE ESPAÑA, S.A.U. | 1 | €2,579,384 | 2026-07-13 |
| BAYER HISPANIA S.L. | 1 | €2,555,130 | 2026-06-19 |
Full buyer profile: what Consejería de Sanidad del Gobierno de Canarias buys and who wins it →
CPV codes
33690000 Medical equipment & pharmaceuticalsDescription
Suministro de los productos farmacéuticos Levatinib, Pemigarinib, Ruxolitinib y Evinacumab para el Complejo Hospitalario Universitario Insular-Materno Infantil de Gran Canaria.